French drugmaker Sanofi reported sharply lower fourth-quarter net profit, hit by growing pricing pressure in the U.S. diabetes market and higher accounting charges.
WSJ.com: US Business, Wall Street Journal: Business
Mon, 02/08/2016 - 11:30pm
French drugmaker Sanofi reported sharply lower fourth-quarter net profit, hit by growing pricing pressure in the U.S. diabetes market and higher accounting charges.